Cheung Jason Pui Yin, Fung Boris, Ip Wing Yuk, Chow Shew-Ping
Department of Orthopaedics and Traumatology, University of Hong Kong Medical Centre, Queen Mary Hospital, Hong Kong.
J Orthop Surg (Hong Kong). 2012 Aug;20(2):214-8. doi: 10.1177/230949901202000216.
To review records of 166 patients who underwent treatment for Mycobacterium marinum tenosynovitis of the hand and wrist to identify factors associated with functional outcome.
Records of 97 men and 69 women aged 13 to 85 (mean, 50) years who underwent treatment for suspected M marinum tenosynovitis of the hand and wrist were retrospectively reviewed. All underwent open biopsy; synovectomy was performed when florid synovitis was present. Rifampicin and ethambutol were usually prescribed. Clarithromycin, minocycline and/or levofloxacin were used as adjuvants if there was drug intolerance, allergy, or relapse. The duration of antibiotic treatment depended on the clinical recovery. Patients were followed up for one year after completion of drug treatment. Functional outcome was considered excellent for those with >195º total active motion (TAM) and >75% return of motion, good for those with 130º to 195º TAM and 50 to 75% return of motion, fair for those with 65º to 129º TAM and 25 to 49% return of motion, and poor for those with<65º TAM and <25% return of motion.
The mean delay in presentation was 4.9 (0.3-120) months. 93 of the patients presented with disabilities (flexion deformity or reduced range of motion), 64 of whom presented one month after injury. 37 (22%) of the patients had received intralesional steroids prior to admission, 30 of whom presented one month after injury. 32 (19%) patients were treated with antibiotics alone, whereas 134 (81%) patients underwent debridement in addition to antibiotic treatment. The mean duration of antibiotic treatment was 7.2 (range, 0-29) months. Of the 156 patients who completed the follow-up, functional outcome was satisfactory in 128 (82%) and unsatisfactory in 28 (17%). Steroid injections and late presentation led to worse functional outcome. Patients with unsatisfactory outcome were more likely to have received intralesional steroid injections (43% [16/37] vs. 10% [12/118], p<0.001, Pearson Chi squared test), have presented >2 months after injury (27% [21/79] vs. 9% [7/77], p=0.004, Pearson Chi squared test), and have undergone synovectomy (23% [28/124]) vs. 0% [0/32], p=0.001, Fisher's exact test). Worse functional outcome correlated with late presentation (r=0.218) and the greater number of debridement procedures (r=0.453).
Delayed antibiotic treatment of M marinum infections and steroid injections were associated with unsatisfactory outcome. Clinicians must have a high index of suspicion for this condition and avoid inappropriate management such as intralesional steroid injections. Public awareness to this condition should be raised.
回顾166例接受手部和腕部海分枝杆菌腱鞘炎治疗患者的记录,以确定与功能结局相关的因素。
回顾性分析97例男性和69例女性患者的记录,年龄在13至85岁(平均50岁),均因疑似手部和腕部海分枝杆菌腱鞘炎接受治疗。所有患者均接受开放性活检;当出现明显滑膜炎时进行滑膜切除术。通常使用利福平和乙胺丁醇。如果存在药物不耐受、过敏或复发,则使用克拉霉素、米诺环素和/或左氧氟沙星作为辅助药物。抗生素治疗的持续时间取决于临床恢复情况。药物治疗完成后对患者进行一年的随访。对于总主动活动度(TAM)>195°且活动度恢复>75%的患者,功能结局被认为优秀;对于TAM为130°至195°且活动度恢复为50%至75%的患者,功能结局为良好;对于TAM为65°至129°且活动度恢复为25%至49%的患者,功能结局为尚可;对于TAM<65°且活动度恢复<25%的患者,功能结局为差。
就诊的平均延迟时间为4.9(0.3 - 120)个月。93例患者存在功能障碍(屈曲畸形或活动范围减小),其中64例在受伤后1个月出现。37例(22%)患者在入院前接受了病灶内类固醇注射,其中30例在受伤后1个月出现。32例(19%)患者仅接受抗生素治疗,而134例(81%)患者除抗生素治疗外还接受了清创术。抗生素治疗的平均持续时间为7.2(范围0 - 29)个月。在156例完成随访的患者中,128例(82%)功能结局满意,28例(17%)不满意。类固醇注射和就诊延迟导致功能结局较差。结局不满意的患者更有可能接受过病灶内类固醇注射(43% [16/37] 对10% [12/118],p<0.001,Pearson卡方检验)、受伤后>2个月就诊(27% [21/79] 对9% [7/77],p = 0.004,Pearson卡方检验)以及接受滑膜切除术(23% [28/124])对0% [0/32],p = 0.001,Fisher精确检验)。较差的功能结局与就诊延迟(r = 0.218)和清创手术次数较多(r = 0.453)相关。
海分枝杆菌感染的抗生素治疗延迟和类固醇注射与不满意的结局相关。临床医生对此病必须有高度的怀疑指数,并避免不适当的处理,如病灶内类固醇注射。应提高公众对此病的认识。